Brain imaging in the preclinical study and prevention of Alzheimer's disease - Eric Reiman

Chief Executive Officer, Banner Research
 Executive Director, Banner Alzheimer's Institute

Dr. Reiman’s research interests include brain imaging, genomics and their application to the study of normal and abnormal human behaviors; the early detection, tracking and study of Alzheimer's disease; and the accelerated evaluation of pre-symptomatic Alzheimer's disease treatments. Dr. Reiman is internationally recognized for his contributions to the fields of brain imaging, the behavioral neurosciences and the pre-symptomatic study of Alzheimer's disease. Dr. Reiman and his colleagues have developed the international Alzheimer's Prevention Initiative to find effective treatments to prevent Alzheimer's disease as quickly as possible.